Regulatory effects of osteoprotegerin on cellular and humoral immune responses
The interaction between receptor activator of nuclear factor-kappaB ligand (RANKL) and RANK has been reported to regulate immunity in addition to bone metabolism. The aim of this study was to determine if osteoprotegerin (OPG), an inhibitor of the RANKL-RANK interaction and possibly a new drug again...
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 109(2003), 3 vom: 15. Dez., Seite 347-54 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , |
| Format: | Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2003
|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
| Schlagworte: | Journal Article Glycoproteins Immunoglobulins Osteoprotegerin Pneumococcal Vaccines Receptors, Cytoplasmic and Nuclear Receptors, Tumor Necrosis Factor TNFRSF11B protein, human Tnfrsf11b protein, mouse Oxazolone mehr... |